CHILDHOOD PULMONARY TUBERCULOSIS CASES SHOWING RESISTANCE TO ISONIAZID BUT SENSITIVE TO RIFAMPICIN BY CBNAAT
Not Applicable
- Conditions
- Health Condition 1: A150- Tuberculosis of lung
- Registration Number
- CTRI/2021/03/032203
- Lead Sponsor
- MAULANA AZAD MEDICAL COLLEGE AND LOK NAYAK HOSPITALNEW DELHI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
children and adolescents up to 18 years of age with pulmonary tuberculosis sensitive to Rifampicin by CBNAAT
Exclusion Criteria
History of taking anti tubercular treatment(ATT)for more than 1 month(re-treatment cases)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of cases showing resistance to Isoniazid among Rifampicin sensitive pulmonary tuberculosis in children and adolescents upto 18 yearsTimepoint: 1year
- Secondary Outcome Measures
Name Time Method Proportion of cases showing resistance to Ethambutol and Pyrazinamide among Rifampicin sensitive pulmonary tuberculosis in children and adolescents up to 18 yearsTimepoint: 1 year